Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",24020,85,1.47 [0.64-3.40],0.3618132024041358
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24524,128,0.60 [0.30-1.18],0.1371408850453481
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24310,892,0.97 [0.75-1.26],0.831528541570317
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Candidiasis,24549,266,0.88 [0.55-1.41],0.6057807186111721
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23852,2423,1.00 [0.86-1.17],0.9789380113803166
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24079,1844,1.10 [0.92-1.32],0.3044687582973246
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,24370,871,1.21 [0.93-1.57],0.1534744027014754
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24481,38,0.66 [0.19-2.32],0.5167569433874428
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23423,566,1.15 [0.83-1.60],0.3929241288945876
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22626,535,1.30 [0.93-1.81],0.1294483404939287
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22853,151,0.75 [0.40-1.40],0.3676654581525994
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18246,1070,1.16 [0.92-1.47],0.2128429793162934
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22655,252,1.60 [0.98-2.59],0.0577154102733414
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24514,1015,1.06 [0.83-1.35],0.6386818327898671
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Mycoses,24607,324,0.68 [0.44-1.04],0.0750600875218799
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23966,548,1.04 [0.75-1.45],0.7954820172150008
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24556,621,1.14 [0.84-1.56],0.4047083683123517
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23629,130,0.56 [0.29-1.11],0.0960580509099946
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24649,29,1.37 [0.33-5.79],0.6648912126803408
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24483,548,1.18 [0.85-1.64],0.3318721309212006
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24507,64,0.66 [0.25-1.72],0.3971490146583297
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24559,154,1.46 [0.78-2.73],0.237135146029152
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24544,139,1.36 [0.70-2.62],0.3659656446180646
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23721,303,0.85 [0.55-1.33],0.4848060820427204
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23625,207,0.95 [0.56-1.62],0.8490649513367347
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23565,66,0.65 [0.25-1.66],0.3683253900099761
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24622,46,1.65 [0.54-5.04],0.3837596635091064
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24593,115,1.00 [0.48-2.06],0.998821618441965
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral warts,24517,39,1.51 [0.43-5.23],0.5178470453196635
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24522,44,0.57 [0.18-1.83],0.3431980528500939
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm,24384,281,0.87 [0.55-1.38],0.5525752983894834
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24571,67,0.98 [0.38-2.55],0.9722412109800158
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24543,68,0.56 [0.22-1.43],0.2258671326829397
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10999,37,0.52 [0.14-1.92],0.3221536764766404
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",24467,1037,0.77 [0.61-0.99],0.0381484538191872
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of meninges,24637,44,0.60 [0.19-1.92],0.3917594949858282
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24616,48,0.60 [0.20-1.85],0.3786328154774788
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24627,80,1.14 [0.48-2.69],0.7710140604822766
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of ovary,13591,85,0.90 [0.39-2.07],0.797652332763167
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24641,245,1.29 [0.79-2.13],0.3102006216192897
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Caecum,24637,186,0.92 [0.52-1.63],0.781388004771223
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24583,50,1.11 [0.37-3.27],0.8542874619751054
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Descending colon,24643,159,1.02 [0.55-1.89],0.9526071064795476
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Rectum,24610,255,0.69 [0.42-1.13],0.1397893904929006
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24577,485,0.80 [0.56-1.14],0.2224120631082801
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24641,271,0.92 [0.58-1.48],0.7454253359898941
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Carcinoma in situ of breast,11650,75,0.74 [0.30-1.82],0.506818863805039
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11690,85,0.76 [0.33-1.77],0.5254037556981312
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",21249,31,0.72 [0.38-1.40],0.3369073218332744
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",21253,35,2.93 [0.79-10.80],0.1072960791345075
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24610,97,0.63 [0.38-1.06],0.08045492824144
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Haemangioma, any site",24610,95,0.30 [0.14-0.66],0.0028343180345822
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Leiomyoma of uterus,13019,364,0.51 [0.34-0.77],0.0012934376367176
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Lung cancer and mesothelioma,18266,160,0.64 [0.34-1.21],0.1682944016844643
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Lymphoid leukaemia,21246,28,0.35 [0.08-1.51],0.1588064040224057
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21349,131,1.82 [0.91-3.65],0.0921580010326598
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",21298,80,1.26 [0.52-3.06],0.6141634791818043
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11739,71,1.05 [0.42-2.63],0.917187181749886
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",21264,46,0.70 [0.22-2.17],0.5346911893396238
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",21273,55,1.36 [0.47-3.95],0.572024623331336
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",21282,64,1.21 [0.45-3.28],0.7072559633242805
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11717,49,2.12 [0.70-6.46],0.1845957431773538
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",21273,55,0.76 [0.27-2.14],0.6067097664353049
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9907,357,0.99 [0.65-1.52],0.9602326678230088
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",21304,86,1.65 [0.70-3.88],0.2480156143681331
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",21267,49,0.84 [0.27-2.60],0.765913249296193
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,21274,56,1.81 [0.63-5.21],0.2700403710901011
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanocytic naevi,24438,194,0.83 [0.47-1.47],0.5256984413011716
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanocytic naevi of trunk,24606,88,1.08 [0.46-2.52],0.8601084329640141
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanoma in situ,21229,41,0.64 [0.19-2.17],0.471135697176762
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",21274,56,0.96 [0.34-2.74],0.9462811687562008
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21324,106,0.92 [0.43-1.97],0.8347606632566664
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",21325,107,0.40 [0.19-0.86],0.0188209790685622
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",21278,60,0.86 [0.31-2.35],0.7687535638096914
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Other benign neoplasms of skin,24487,133,1.21 [0.62-2.39],0.5771916353558506
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21788,570,1.81 [1.30-2.53],0.0004788974274188
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21818,600,1.89 [1.37-2.62],0.0001223445723529
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24394,266,1.45 [0.90-2.33],0.1252433890262199
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,23382,43,1.23 [0.38-3.97],0.7302202294504992
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,24196,68,0.78 [0.31-1.99],0.6052050261483348
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23929,1986,1.07 [0.90-1.28],0.4370147912539168
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23606,20,0.33 [0.06-1.79],0.197292824638315
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,24330,29,1.29 [0.31-5.35],0.7299049473052114
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,24249,910,1.18 [0.91-1.52],0.207191432780682
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,24249,910,1.18 [0.91-1.52],0.207191432780682
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,23388,49,1.95 [0.65-5.89],0.2351410267914768
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24400,814,1.12 [0.85-1.46],0.4254623228452787
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,24398,97,2.33 [1.06-5.14],0.0355648063968407
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,24176,48,0.98 [0.32-3.04],0.97188223964302
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,24167,39,2.36 [0.69-8.06],0.1717966036466695
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24475,174,1.06 [0.59-1.90],0.8546601765055413
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24578,60,0.62 [0.23-1.65],0.3355248341122848
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24451,150,1.27 [0.67-2.38],0.4644462233222562
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23648,62,2.11 [0.80-5.58],0.1331983775821736
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21143,183,1.83 [1.03-3.25],0.0396937279356226
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22918,110,0.33 [0.16-0.69],0.0034216812941241
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22937,129,0.48 [0.29-0.78],0.0031766271062547
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20992,32,1.51 [0.37-6.10],0.5610379201226506
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22869,63,0.35 [0.13-0.91],0.0310039235473597
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22558,125,0.70 [0.35-1.39],0.31175750388442
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",24517,146,0.84 [0.44-1.57],0.5761419675911976
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,24418,47,0.94 [0.30-2.93],0.9129563990105636
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,24403,32,0.81 [0.44-1.49],0.4967852504325664
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,24281,1475,1.09 [0.89-1.33],0.4113994062684896
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,22070,1435,1.05 [0.86-1.29],0.6314193354823502
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20999,39,0.98 [0.28-3.49],0.979414721137042
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23186,53,2.01 [0.69-5.80],0.1986176412035857
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21129,169,1.58 [0.87-2.88],0.1334692933757751
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21015,55,1.33 [0.45-3.90],0.601697474023172
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23104,2144,0.86 [0.73-1.02],0.0884060884296364
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21071,111,0.57 [0.27-1.18],0.1286923776516253
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,21313,353,1.19 [0.78-1.80],0.4193582832269802
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24560,233,2.17 [1.31-3.61],0.0027745304454651
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,24421,94,3.13 [1.42-6.93],0.0048036475988203
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21053,93,1.43 [0.63-3.22],0.3920185529317888
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20995,35,1.70 [0.46-6.33],0.4308125393469699
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24271,1138,0.97 [0.77-1.22],0.8052145407739524
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21076,116,2.71 [1.32-5.57],0.0067061326217328
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21098,138,3.47 [1.79-6.73],0.0002312287103981
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21309,349,1.25 [0.83-1.90],0.2875565338523861
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21017,57,3.35 [1.20-9.37],0.021077016598117
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,24415,88,3.24 [1.43-7.34],0.005001422312762
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,21233,273,0.90 [0.56-1.44],0.6526512038645527
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,21236,276,0.93 [0.58-1.49],0.7693183279181963
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,22486,53,0.73 [0.25-2.10],0.5547050374000082
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24028,3068,0.87 [0.75-1.00],0.0439929605633845
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23160,27,1.63 [0.37-7.21],0.5174344984653365
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23186,53,0.60 [0.21-1.73],0.3429580873976039
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24486,1728,0.96 [0.80-1.16],0.7036981736118644
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24489,1725,0.96 [0.80-1.16],0.6979379946869682
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23165,32,0.63 [0.16-2.44],0.508674935176318
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,24360,1105,1.06 [0.84-1.33],0.6478039117033295
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21766,806,1.09 [0.83-1.43],0.5405465986310272
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24640,112,1.63 [0.79-3.34],0.18421327279989
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,24402,31,2.79 [0.70-11.10],0.1454427431558221
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23336,81,1.82 [0.77-4.29],0.1689834744238577
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23355,100,0.96 [0.44-2.06],0.9114978333890112
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21071,111,1.57 [0.75-3.31],0.2321031014318366
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,23035,109,2.78 [1.33-5.82],0.00670266811311
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1537,60,1.41 [0.53-3.74],0.48755051802333
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1634,169,1.21 [0.68-2.14],0.517536854571085
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22963,37,1.09 [0.29-4.10],0.8991072764899695
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1509,32,12.91 [3.71-44.98],5.889399378352753e-05
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24281,1355,0.85 [0.69-1.05],0.1230644309325372
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,24433,62,0.57 [0.21-1.51],0.2547649324232168
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22682,249,1.04 [0.64-1.68],0.869778647040065
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21326,366,1.52 [1.01-2.28],0.0433312592544785
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24567,152,1.20 [0.64-2.25],0.5793831287373604
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23978,49,3.40 [1.09-10.56],0.0343028935296235
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Angina pectoris,23515,715,0.85 [0.63-1.13],0.263959570397348
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Aortic aneurysm,24023,94,1.63 [0.72-3.70],0.2422464168743991
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23957,28,2.31 [0.53-10.14],0.2654642232233398
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",24025,96,1.60 [0.72-3.54],0.250186484641783
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17504,823,1.00 [0.76-1.32],0.9877180777521648
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,AV-block,22424,164,0.83 [0.45-1.54],0.5594729514261665
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24620,233,1.35 [0.81-2.26],0.2469753138617165
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cardiac arrest,16777,96,1.23 [0.55-2.77],0.6179288153798088
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22379,119,0.80 [0.39-1.64],0.5454918099185493
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",22336,76,0.57 [0.23-1.40],0.2222024399149834
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24651,15,0.86 [0.45-1.64],0.6385615768405581
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Conduction disorders,22741,481,1.15 [0.80-1.65],0.445384789148357
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23995,1204,0.94 [0.75-1.17],0.5708076802786954
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22900,5418,0.79 [0.71-0.88],1.993336963467793e-05
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23616,160,1.37 [0.74-2.55],0.3129635975140653
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Endocarditis,22301,41,0.73 [0.22-2.47],0.6147421074294621
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24539,463,1.28 [0.90-1.83],0.1709649210698179
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypertension,23409,4411,0.73 [0.65-0.82],2.3383160727100946e-07
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23418,4420,0.74 [0.66-0.83],4.352538731020214e-07
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24490,49,1.35 [0.45-4.08],0.5893361449811455
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19080,82,2.21 [0.94-5.22],0.0698730664484488
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19040,42,45.59 [13.88-149.68],3.036249300462019e-10
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypotension,24560,615,1.37 [1.00-1.87],0.0510563451698752
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,24170,59,0.70 [0.26-1.90],0.4827177674762626
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24146,1346,0.91 [0.73-1.12],0.3676491575923317
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24447,282,0.87 [0.55-1.38],0.5572564446870624
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Left bundle-branch block,22447,187,1.19 [0.67-2.11],0.5474230520341034
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24423,542,1.34 [0.96-1.87],0.0872949160084329
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",23241,441,1.59 [1.09-2.31],0.0154761826570986
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24600,106,3.89 [1.81-8.32],0.0004783131092906
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24636,187,1.67 [0.94-2.94],0.0791296700162857
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Oesophageal varices,23487,31,1.04 [0.25-4.23],0.9587704562848424
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other aneurysm,23971,42,1.46 [0.44-4.82],0.5381724866605653
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other arrhythmias,22487,227,0.63 [0.37-1.06],0.080189183993196
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23989,60,3.80 [1.41-10.25],0.0083410348155056
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,24062,133,1.76 [0.90-3.42],0.0967353314307354
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,22377,117,1.16 [0.57-2.39],0.6820143717837573
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other disorders of veins,23520,64,2.16 [0.82-5.68],0.1205378780375287
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,23502,46,0.83 [0.27-2.61],0.7520927476040644
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23944,35,0.94 [0.25-3.58],0.9299592778622312
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,23537,81,2.02 [0.85-4.79],0.1092793075298875
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22791,531,0.96 [0.68-1.35],0.8147119408006653
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23987,42,2.25 [0.69-7.38],0.1805838211787238
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,24241,312,1.32 [0.85-2.05],0.2136687612829525
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24245,139,1.05 [0.55-2.00],0.8864279033096769
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",24120,211,0.82 [0.48-1.38],0.4499309284500248
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16895,214,0.94 [0.55-1.62],0.8335466481882857
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Peripheral artery disease,24091,184,1.55 [0.88-2.74],0.1324219403804149
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23677,221,1.21 [0.71-2.05],0.4808765933049972
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Pulmonary embolism,24406,300,1.23 [0.78-1.92],0.3697565182910359
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24612,289,1.32 [0.84-2.09],0.2271257921241144
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Right bundle-branch block,22413,153,1.20 [0.63-2.28],0.5721300989104545
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24242,136,1.08 [0.56-2.07],0.8204704122712617
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,24013,104,0.83 [0.39-1.77],0.6235421190451134
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24440,329,0.85 [0.56-1.30],0.4582210438773588
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24417,363,0.90 [0.60-1.35],0.6079340387113806
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,24150,52,1.55 [0.53-4.53],0.4264933830791477
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23978,50,2.04 [0.66-6.30],0.2140492960088905
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Transient ischemic attack,24285,120,0.99 [0.48-2.02],0.9710293359550644
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,24042,161,0.83 [0.45-1.52],0.5409068134663269
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Varicose veins,23731,275,1.36 [0.85-2.18],0.2014502867119907
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23939,47,1.22 [0.39-3.81],0.7348133858864785
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24492,467,1.26 [0.88-1.81],0.2029028665280405
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24503,336,0.39 [0.27-0.55],2.1950205879015058e-07
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21949,1268,1.10 [0.88-1.37],0.4002377319867566
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Any mental disorder,23969,3288,0.94 [0.82-1.08],0.4051467077976807
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24447,393,0.31 [0.21-0.45],3.0253683936200206e-09
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22186,1505,1.05 [0.86-1.28],0.6652124130970176
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20759,78,0.90 [0.37-2.16],0.811395850246516
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Smoking dependency,24158,1368,1.10 [0.89-1.36],0.3702586955662635
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22256,1575,0.89 [0.73-1.08],0.2325624903579806
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Vascular dementia,24549,18,1.86 [0.30-11.59],0.5065279327093061
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Alzheimer disease,24650,65,0.96 [0.36-2.52],0.9263855055842872
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Bell's palsy,23152,68,1.55 [0.60-3.97],0.3640696037236361
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23513,429,1.23 [0.85-1.79],0.2708664121280918
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Cerebral cysts,24329,180,0.56 [0.32-1.00],0.0516844544551099
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24571,204,0.75 [0.44-1.30],0.305616077805973
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,24515,21,0.77 [0.41-1.45],0.414832309966917
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24639,50,1.41 [0.47-4.24],0.5383248991752607
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",24200,51,0.32 [0.11-0.93],0.0365730547030463
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Epilepsy,23262,234,1.38 [0.83-2.31],0.2115469837418123
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,24213,1185,1.15 [0.92-1.44],0.2280407507452711
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24623,172,1.21 [0.67-2.19],0.5278045669122524
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24195,1484,1.06 [0.87-1.30],0.5418064390190847
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Generalized epilepsy,24315,48,1.58 [0.51-4.90],0.4254787474856798
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Hemiplegia,24517,150,0.71 [0.38-1.33],0.2805623092405019
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Hydrocephalus,24193,44,1.49 [0.46-4.83],0.5020165759246293
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24628,62,1.78 [0.67-4.73],0.2489865942726974
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,23154,70,1.25 [0.49-3.16],0.642884384672253
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,23157,73,0.84 [0.34-2.10],0.7116309595258952
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Memory loss,24516,68,1.07 [0.42-2.77],0.88286046674412
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Migraine,23397,369,1.25 [0.83-1.88],0.2830018672961318
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24573,334,1.11 [0.72-1.71],0.6280700344738482
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Motor neuron disease,17913,92,0.58 [0.26-1.32],0.194139886590509
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24455,136,0.72 [0.37-1.41],0.3376058030281108
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",24105,1021,1.09 [0.85-1.39],0.491888962571352
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Neurological diseases,23347,2724,0.96 [0.83-1.12],0.6091600456784955
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,24563,69,0.64 [0.25-1.62],0.3437307077266975
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23437,353,1.28 [0.85-1.94],0.2369737971484975
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24586,207,1.29 [0.75-2.21],0.3559758095807414
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20553,288,0.60 [0.38-0.95],0.0308110403587464
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,24203,54,1.75 [0.60-5.09],0.3041708029233106
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other disorders of nervous system,24257,108,1.06 [0.50-2.23],0.8830609697190436
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24524,73,1.07 [0.43-2.64],0.8818562300717826
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other facial nerve disorders,23170,86,1.39 [0.60-3.21],0.4437146653197056
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other headache syndromes,23083,55,0.64 [0.23-1.80],0.4028820953938015
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other neurological diseases,24543,394,0.74 [0.50-1.10],0.1347382123232126
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other sleep disorders,23550,522,1.02 [0.73-1.43],0.9151619820219596
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Parkinson's disease,24638,79,2.00 [0.83-4.82],0.1245563083934387
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,24205,56,0.36 [0.13-1.03],0.0560090808696527
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Restless leg syndrome,24649,34,1.12 [0.30-4.12],0.8682884265681609
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Sleep apnoea,24427,453,0.95 [0.66-1.37],0.7939930506229262
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24411,32,2.05 [0.51-8.27],0.3145069605066272
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24634,116,0.68 [0.33-1.39],0.2889967900871633
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,23112,28,0.68 [0.16-2.92],0.6044187782625428
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24650,66,0.94 [0.36-2.45],0.8947383960909818
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),24537,17,2.03 [0.31-13.31],0.4604855155672186
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,24217,35,0.79 [0.21-2.91],0.7207358836245423
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,24328,189,0.54 [0.31-0.94],0.0295816629170294
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24573,173,2.09 [1.17-3.74],0.0130273257268829
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23979,34,0.45 [0.12-1.70],0.2411396118533131
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,24013,68,0.94 [0.36-2.42],0.8938502046972667
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24566,28,0.61 [0.14-2.59],0.4989859759609671
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,24479,56,0.45 [0.16-1.25],0.127170922674236
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1512,35,15.19 [4.60-50.21],8.17450121653143e-06
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1788,72,1.65 [0.70-3.91],0.2539870171874487
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,24255,73,0.82 [0.33-2.04],0.6664679236790716
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24543,555,0.87 [0.63-1.21],0.4203853670006163
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24370,425,0.78 [0.54-1.14],0.1950385849248507
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,24069,124,0.76 [0.38-1.51],0.4311422080857563
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24567,428,0.75 [0.51-1.09],0.1261149910094282
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24643,50,1.40 [0.46-4.24],0.552032199211818
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24498,359,0.58 [0.39-0.88],0.009723710572336
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24613,190,0.55 [0.31-0.95],0.0332383311696657
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24594,120,0.73 [0.36-1.47],0.3711677405977477
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23960,15,0.41 [0.06-3.05],0.3867332019095649
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23972,27,1.86 [0.41-8.40],0.4181146985217626
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23975,30,0.67 [0.16-2.72],0.5752504555762988
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24608,343,1.00 [0.66-1.51],0.9853294788209236
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,24348,83,0.62 [0.27-1.44],0.2658030758916582
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,24161,22,0.93 [0.18-4.91],0.9343104883381222
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,24485,62,0.76 [0.28-2.01],0.5755600877150561
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24553,130,0.49 [0.25-0.96],0.0363820348305608
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,24286,147,0.56 [0.29-1.06],0.0732360865847463
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24544,70,0.95 [0.38-2.38],0.9059407822855868
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24491,226,1.20 [0.72-2.00],0.490186951072603
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,24282,100,0.57 [0.26-1.22],0.14683138860102
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,24020,958,0.66 [0.52-0.85],0.0010695115313398
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24531,108,0.43 [0.21-0.90],0.0246800195038474
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24629,102,2.05 [0.95-4.41],0.0655955293593582
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,24179,234,0.77 [0.46-1.27],0.3000586836991161
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,24458,35,1.38 [0.37-5.11],0.6340557573528199
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24628,35,1.94 [0.52-7.30],0.3246727813422883
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23980,35,1.29 [0.35-4.75],0.7060525766177601
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,24049,104,0.89 [0.42-1.91],0.7669661912225988
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,24046,58,0.73 [0.26-2.00],0.535561339442873
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,24189,50,2.14 [0.71-6.47],0.1765921425992608
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",24036,48,0.72 [0.40-1.31],0.2843410233380744
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,24312,47,0.44 [0.14-1.37],0.1575325280717682
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",24347,82,0.94 [0.40-2.20],0.8864638891407814
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,24019,74,0.92 [0.38-2.23],0.8479342325139674
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,24096,108,0.49 [0.23-1.05],0.0683739020215191
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,24019,31,1.93 [0.49-7.66],0.3503912788764813
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23796,734,0.72 [0.54-0.95],0.0202481209758391
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23989,44,0.69 [0.22-2.18],0.5217130397147094
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24455,273,0.65 [0.40-1.03],0.0671790895943921
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,24214,32,1.15 [0.29-4.57],0.846228495682661
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),24295,113,1.39 [0.68-2.86],0.3706721967615954
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24466,56,0.62 [0.22-1.75],0.370395160389381
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24609,84,0.92 [0.39-2.16],0.8410111974796155
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24539,128,1.15 [0.58-2.27],0.6909106652830914
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,24461,51,2.28 [0.77-6.71],0.1363919359247182
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,24461,51,0.51 [0.17-1.50],0.2187016307342878
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24565,484,1.01 [0.71-1.43],0.9677151026403524
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,24380,299,0.98 [0.62-1.54],0.9263582954319196
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,24170,89,0.78 [0.35-1.77],0.5568926330588619
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,24152,71,1.41 [0.57-3.52],0.4601810591964251
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute pharyngitis,24385,69,0.55 [0.22-1.39],0.2074441811755802
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24530,214,0.54 [0.32-0.92],0.0234604413842837
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,24374,58,0.87 [0.32-2.37],0.7820340838317964
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,All influenza,23478,71,1.92 [0.79-4.71],0.1518041894910443
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),23477,70,2.06 [0.84-5.09],0.1151469932633359
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Allergic asthma (mode),18225,119,0.36 [0.18-0.75],0.0060967300240422
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Allergic rhinitis,24524,284,0.84 [0.52-1.33],0.4519517404118919
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19542,1573,0.53 [0.44-0.65],3.5330545487396783e-10
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19648,1542,0.53 [0.44-0.65],7.419167568151487e-10
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),24395,88,2.03 [0.90-4.57],0.0894701999241601
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",23458,51,1.27 [0.44-3.66],0.6640610035680926
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Bronchiectasis,21919,160,0.96 [0.52-1.77],0.9001290500536477
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21793,34,0.75 [0.39-1.43],0.3773690332709958
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23863,2104,0.65 [0.55-0.78],9.994347818393802e-07
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23316,60,0.32 [0.12-0.87],0.0259418916839175
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Chronic sinusitis,23404,148,0.86 [0.45-1.65],0.6583288138097723
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24558,646,0.84 [0.62-1.13],0.2492503361398263
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Deviated nasal septum,23377,121,0.83 [0.40-1.71],0.6066104460537973
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22908,3805,0.79 [0.69-0.90],0.0002627140298033
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23603,347,0.79 [0.52-1.20],0.2606883529240758
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Early onset COPD,24377,465,0.85 [0.59-1.21],0.3698135994966194
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Emphysema,21927,168,0.70 [0.38-1.28],0.246941007626302
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23495,102,0.69 [0.32-1.48],0.3395643381462388
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24483,1076,1.08 [0.86-1.37],0.5046245305127031
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Interstitial lung disease,23517,124,0.76 [0.38-1.51],0.4288320489043995
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Later onset COPD,23326,181,0.80 [0.45-1.44],0.4620796920568284
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24643,138,0.90 [0.47-1.75],0.7629995592004366
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Nasal polyp,23363,107,0.48 [0.23-1.04],0.061701546209002
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24451,572,1.22 [0.89-1.69],0.2195314711056492
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other diseases of pleura,24484,1126,1.07 [0.85-1.35],0.5522979671038207
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,24064,808,0.72 [0.55-0.95],0.0192876700325837
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other pleural conditions,23391,33,0.84 [0.21-3.33],0.8030744978617695
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24595,182,0.80 [0.45-1.41],0.4427588116625192
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24574,770,0.99 [0.75-1.31],0.953700003660545
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pleural effusion,23901,543,1.04 [0.74-1.45],0.8198437077918593
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pleural plaque,23407,49,1.26 [0.41-3.89],0.6908727362949558
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24293,886,1.05 [0.81-1.37],0.7001710892503377
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24625,120,0.95 [0.47-1.92],0.8845299298090373
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pneumothorax,23416,58,1.01 [0.36-2.86],0.9806042993129428
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pollen allergy,24624,246,0.78 [0.48-1.29],0.3389109842782191
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pulmonary oedema,24449,36,1.50 [0.42-5.35],0.5325735756185326
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Respiratory insufficiency,18139,33,0.39 [0.10-1.50],0.1715819665744888
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24431,552,1.32 [0.95-1.83],0.1020939790273484
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23540,284,0.82 [0.52-1.32],0.418462374012799
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Viral pneumonia,23575,168,0.98 [0.54-1.77],0.950152929178599
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",24409,144,0.78 [0.42-1.48],0.4548339916612787
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,14193,88,0.86 [0.37-1.98],0.7204169539367882
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18855,60,0.41 [0.15-1.10],0.0760382776965576
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute appendicitis,24469,137,0.70 [0.36-1.38],0.3054385019749686
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute gastritis,19690,62,1.46 [0.54-3.93],0.4555592478906546
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute pancreatitis,23203,155,0.36 [0.19-0.67],0.0012272098002715
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute peritonitis,24238,61,4.54 [1.71-12.05],0.0024197933282156
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23953,79,0.47 [0.27-0.81],0.0066313868644153
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Barrett oesophagus,19948,320,0.92 [0.60-1.43],0.7232296475499864
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",23100,52,0.92 [0.32-2.67],0.8742819425138393
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",24286,52,0.94 [0.32-2.75],0.9116766896792092
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Cholecystitis,23206,158,0.69 [0.37-1.28],0.2406763438833877
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Cholelithiasis,23888,840,0.77 [0.59-1.00],0.05340567286002
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Chronic gastritis,19851,223,0.92 [0.55-1.55],0.756994574462373
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Chronic pancreatitis,23088,40,1.18 [0.35-3.96],0.7933079885304251
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24518,77,1.09 [0.46-2.59],0.8483246358330382
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Coeliac disease,23371,101,0.74 [0.34-1.61],0.4467434132350398
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Collagenous colitis,23250,50,0.77 [0.25-2.31],0.6365812533502926
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24475,187,0.56 [0.32-0.99],0.045414528636826
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Constipation,24457,1039,0.89 [0.70-1.13],0.3412638275136079
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Crohn disease,23282,82,0.84 [0.35-2.00],0.6938996627132707
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24335,54,0.73 [0.25-2.11],0.5627540914424486
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Crohn's disease NAS,23277,77,1.01 [0.41-2.48],0.9835018487869642
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Dental caries,23905,232,0.78 [0.47-1.30],0.3377155792610777
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22775,1612,0.96 [0.79-1.17],0.7164365578205961
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of appendix,24508,176,0.77 [0.42-1.40],0.3876306833227169
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of liver,24545,671,0.57 [0.42-0.76],0.0001747021504494
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23087,3459,0.94 [0.83-1.08],0.3974386085869203
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",24215,542,0.92 [0.66-1.29],0.633239921533443
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24572,395,1.26 [0.85-1.87],0.2419517358774636
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23789,116,0.80 [0.39-1.63],0.5326550038209215
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23650,62,0.41 [0.16-1.10],0.0766642409041298
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of the digestive system,24395,1125,0.94 [0.74-1.18],0.5932932742939958
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of tongue,23654,110,1.32 [0.62-2.79],0.4698337283857386
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",24189,1141,0.75 [0.60-0.95],0.0146980456443142
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20972,2177,0.93 [0.79-1.10],0.405814754669865
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Duodenal ulcer,19760,132,0.65 [0.33-1.28],0.2093379008579137
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24584,101,0.58 [0.27-1.26],0.1719522767598904
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24532,74,0.84 [0.34-2.11],0.7139177049891039
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23969,95,0.95 [0.43-2.09],0.8993109282133286
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18955,160,0.57 [0.31-1.05],0.0727727812400139
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Functional dyspepsia,20088,460,0.83 [0.57-1.19],0.3022352930596464
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastric ulcer,19885,257,0.81 [0.50-1.31],0.3982841087502636
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21637,2009,0.87 [0.73-1.04],0.1206601254174722
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20001,373,0.79 [0.53-1.18],0.256063279730248
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20066,7160,0.92 [0.84-1.01],0.0859199344231018
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,GI-bleeding,24171,901,0.98 [0.76-1.27],0.8832066887104896
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23733,60,1.30 [0.47-3.54],0.6140664661488723
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19607,1140,1.03 [0.82-1.30],0.7801671674041829
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23922,48,0.82 [0.27-2.51],0.7316509637680073
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Hernia,23597,2434,0.97 [0.83-1.14],0.7237726637286344
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Impacted teeth,24541,69,0.77 [0.30-1.99],0.5940765996902877
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Impaction of intestines,18827,32,3.20 [0.83-12.39],0.0921908326425498
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Inguinal hernia,21775,612,0.85 [0.61-1.17],0.3158410192761106
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",21236,73,1.00 [0.39-2.57],0.9990990271470171
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18861,66,0.74 [0.28-1.94],0.5422747461969932
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23392,122,0.79 [0.39-1.60],0.5040781375837404
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19314,519,1.23 [0.88-1.73],0.2260646769148508
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24627,346,0.51 [0.34-0.77],0.001388511325655
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23821,621,1.03 [0.75-1.41],0.8566124629779504
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23981,781,1.02 [0.77-1.35],0.8871243631376883
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19755,127,0.73 [0.37-1.47],0.3856796662456836
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oesophagitis,20070,442,1.03 [0.71-1.49],0.8850960015595746
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24610,122,0.94 [0.46-1.91],0.8548972786849525
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,21208,45,1.18 [0.37-3.75],0.776405562283088
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19957,1162,0.91 [0.72-1.14],0.3973628989119659
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,23227,179,0.84 [0.47-1.50],0.5598662525960852
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,23193,145,0.93 [0.49-1.77],0.8273223412737926
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of intestine,20154,1359,0.90 [0.73-1.11],0.3081468717817141
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of intestines,23164,4369,0.94 [0.84-1.06],0.3442062995671435
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23653,177,0.88 [0.49-1.59],0.6727681174112269
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of liver,24411,537,0.61 [0.44-0.86],0.0040092228715547
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20115,487,0.89 [0.62-1.27],0.5188223745406708
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of pancreas,23124,76,0.87 [0.36-2.11],0.7659209755693401
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24524,347,1.08 [0.71-1.64],0.7200681775435345
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20313,685,0.96 [0.71-1.29],0.7775443505935311
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,24183,913,0.99 [0.77-1.28],0.944196244792486
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23825,152,1.12 [0.59-2.09],0.7334677351377543
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19879,1084,0.85 [0.68-1.08],0.1827912598575941
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21212,1584,1.03 [0.84-1.25],0.7946262078387204
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23950,76,0.69 [0.28-1.67],0.4068008746235799
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23880,680,1.02 [0.76-1.38],0.8787963075266214
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19009,214,1.30 [0.77-2.22],0.3296910581560124
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24517,87,1.08 [0.46-2.52],0.861226156891714
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19111,316,1.17 [0.76-1.81],0.4803630169812916
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23396,126,1.11 [0.56-2.22],0.7652709239004574
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24640,56,1.54 [0.54-4.37],0.4202652616841138
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23686,117,1.31 [0.63-2.71],0.4646848125125349
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Toxic colitis,23223,23,2.48 [0.49-12.53],0.272863926254265
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19799,171,0.68 [0.37-1.24],0.2071393927039131
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ulcerative colitis,23334,134,1.20 [0.61-2.36],0.6070486361339242
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23317,117,0.99 [0.48-2.06],0.9873175433823512
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Umbilical hernia,21405,242,1.28 [0.77-2.12],0.3339142717304383
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18893,98,1.21 [0.56-2.63],0.6308774631938467
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ventral hernia,21375,212,1.03 [0.60-1.75],0.9177985141243344
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Volvulus,18853,58,1.22 [0.44-3.36],0.7006166250821226
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24609,140,1.59 [0.82-3.11],0.1706546549921695
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,24412,75,0.99 [0.41-2.41],0.9814107457579516
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23314,133,1.70 [0.86-3.36],0.1266167191482408
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,24070,499,1.06 [0.75-1.51],0.7362947504252488
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23756,185,1.19 [0.67-2.11],0.554265590056075
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,23334,153,0.98 [0.52-1.82],0.9422804594349384
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,24417,209,0.82 [0.48-1.41],0.4764214334863289
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24562,354,0.82 [0.54-1.24],0.3412107564670855
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,24249,41,0.76 [0.23-2.59],0.6648482801428115
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23325,2308,0.98 [0.83-1.16],0.8256932476158372
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,24232,382,0.78 [0.52-1.16],0.2156229111615447
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,24117,267,1.02 [0.63-1.64],0.940013635843022
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,24287,716,1.08 [0.81-1.45],0.6046706117291155
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24638,43,0.72 [0.40-1.30],0.2732244977113162
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,23235,54,1.15 [0.40-3.27],0.7999809367478118
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23888,38,0.91 [0.26-3.20],0.8891737644542131
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,24411,203,0.83 [0.48-1.44],0.516013042423376
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23451,270,0.97 [0.60-1.56],0.892899869374515
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,23215,34,1.62 [0.42-6.21],0.478499838559805
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24574,66,1.13 [0.44-2.92],0.8051177041739049
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23691,120,0.97 [0.47-1.97],0.922804805050663
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24472,135,0.41 [0.21-0.79],0.0079846771128004
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,24233,25,0.60 [0.13-2.84],0.5206478101434522
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,23229,48,0.95 [0.30-2.96],0.9262704375716292
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,24186,1005,1.21 [0.95-1.55],0.1301708171592522
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23481,300,0.89 [0.56-1.40],0.6046148204924204
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,23219,38,1.19 [0.34-4.20],0.7908497616790439
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24575,238,0.60 [0.36-0.99],0.0436023800123487
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,24263,55,1.20 [0.43-3.36],0.7280807741021209
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24531,194,0.59 [0.34-1.03],0.064693217327429
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24623,154,1.45 [0.77-2.74],0.2528458269358755
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,23292,111,1.91 [0.90-4.03],0.0899600199726014
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23356,175,1.10 [0.61-2.00],0.7440026461485856
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24617,148,1.45 [0.76-2.78],0.2618108398093237
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",23299,118,1.97 [0.98-3.96],0.0579716961315642
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24618,110,0.67 [0.32-1.39],0.2786774503332413
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21609,120,1.34 [0.66-2.73],0.4187500635536766
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22987,4181,0.96 [0.86-1.09],0.5543254608744336
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21771,2965,0.95 [0.82-1.09],0.436712255579146
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21575,86,0.93 [0.40-2.16],0.8575139685440258
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,22084,142,1.57 [0.82-3.01],0.1761160929991427
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,22087,145,0.87 [0.45-1.65],0.6615551635142243
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,24439,106,1.55 [0.73-3.29],0.2505116155416493
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21985,43,1.15 [0.35-3.72],0.818947583515201
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19491,685,0.97 [0.72-1.30],0.8347704202166312
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24592,116,1.42 [0.69-2.91],0.336430741452747
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,22202,260,0.80 [0.50-1.29],0.3627718542717287
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21535,5598,0.97 [0.87-1.08],0.5564439019740098
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23387,100,1.20 [0.55-2.62],0.6436304580502106
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21599,110,0.53 [0.25-1.10],0.0887507362468568
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,22045,556,0.91 [0.66-1.27],0.5965440825276661
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23838,1896,0.91 [0.76-1.09],0.3147248766834314
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21696,207,0.68 [0.39-1.18],0.1736212023523737
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21755,266,1.03 [0.64-1.65],0.9027670243206484
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21625,136,0.40 [0.21-0.79],0.0079881181603373
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,24162,33,0.47 [0.12-1.81],0.2714092667289525
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19978,1172,0.97 [0.78-1.22],0.8205782840470084
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19152,346,0.82 [0.54-1.24],0.3425819645032487
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24600,336,0.86 [0.56-1.32],0.478703412701297
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18875,69,0.64 [0.25-1.64],0.3540819868229156
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19120,314,1.35 [0.87-2.09],0.1771794952236912
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21788,299,1.10 [0.70-1.73],0.6701851166739989
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19487,681,1.31 [0.97-1.77],0.0762606002562585
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21968,26,3.73 [0.81-17.11],0.0899266875952053
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22446,504,1.12 [0.79-1.58],0.5311693323875858
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,22200,258,1.37 [0.85-2.23],0.1992378893879785
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19438,632,1.25 [0.92-1.71],0.1594517483126814
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21559,70,0.80 [0.32-2.02],0.6383899399553858
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21545,56,1.40 [0.49-3.95],0.5273500671947655
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,23342,55,1.25 [0.44-3.54],0.6795136679843911
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24350,1063,1.21 [0.96-1.54],0.1105308272502174
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23891,604,0.93 [0.68-1.28],0.6752200525693097
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24542,314,0.95 [0.61-1.46],0.7980335606228637
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,20414,1608,0.99 [0.82-1.20],0.9372952362927844
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18874,68,1.55 [0.59-4.02],0.3710668946939841
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21560,71,0.96 [0.38-2.40],0.9227418386350502
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18832,26,1.24 [0.27-5.70],0.7839851586403206
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18909,103,1.29 [0.60-2.77],0.5096550652104751
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23501,214,1.88 [1.11-3.21],0.0198775795611508
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23512,225,0.98 [0.59-1.66],0.9532431987845488
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24614,77,1.09 [0.45-2.63],0.8455012727283151
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23356,1414,0.97 [0.79-1.19],0.7623368257088737
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21599,110,1.11 [0.53-2.34],0.7824579777095172
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18918,112,1.20 [0.58-2.49],0.6196616284856673
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22513,571,0.99 [0.71-1.37],0.9415011377861836
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20647,1841,1.07 [0.89-1.28],0.4911910883402122
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,24182,53,0.64 [0.22-1.84],0.4034258251536524
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24625,72,0.96 [0.39-2.38],0.9271846156849306
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21560,71,1.05 [0.42-2.65],0.9117889288147868
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",22480,991,1.18 [0.92-1.51],0.1822256990357028
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21552,63,0.49 [0.18-1.30],0.1531962615041042
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19826,1020,1.02 [0.80-1.29],0.8905546380993523
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23384,97,1.48 [0.67-3.26],0.335844873794499
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21548,59,2.29 [0.82-6.42],0.1143980710048597
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,22046,104,0.71 [0.33-1.51],0.3717746254040658
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21844,355,1.35 [0.89-2.03],0.1544429515657955
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24320,191,0.64 [0.37-1.12],0.1152677248234987
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,22372,430,1.09 [0.76-1.58],0.6317591028658213
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24551,299,0.88 [0.56-1.37],0.5618412942565095
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24633,35,0.78 [0.43-1.43],0.422839649417539
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21678,189,1.11 [0.63-1.96],0.7197140836974865
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19757,556,0.92 [0.66-1.27],0.6072084423895112
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21934,445,1.11 [0.77-1.60],0.5817682749546889
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21643,154,0.64 [0.34-1.22],0.1782180454300554
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18841,35,0.87 [0.24-3.15],0.8360825365954527
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20404,1598,0.91 [0.75-1.11],0.3611096306749213
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19212,406,0.94 [0.65-1.38],0.7614844665930883
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,24209,80,0.60 [0.26-1.43],0.251668165499023
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24582,45,2.06 [0.65-6.51],0.2170626297312081
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",23211,27,2.28 [0.53-9.76],0.2676526865217873
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18880,74,0.95 [0.39-2.31],0.9032878711196974
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,22026,84,0.96 [0.41-2.25],0.9325838325313252
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19124,318,0.90 [0.59-1.38],0.6287081209086469
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21732,243,1.17 [0.71-1.92],0.5357326164109328
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,22139,197,0.93 [0.54-1.61],0.7970726977905633
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,22038,96,0.61 [0.28-1.34],0.2202283387090377
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20820,44,1.33 [0.42-4.27],0.6270779379464728
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24636,38,0.81 [0.44-1.48],0.4903112621668096
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,22030,541,1.15 [0.82-1.61],0.4153251168097625
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],24205,76,0.87 [0.36-2.09],0.7484057387755296
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23684,2195,0.99 [0.84-1.17],0.8869622356040967
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21592,103,0.83 [0.38-1.79],0.636613955212423
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,22269,327,1.00 [0.66-1.54],0.984126027685332
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,23373,170,0.61 [0.34-1.10],0.097894808104143
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,22078,136,0.95 [0.49-1.84],0.8724719482338217
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22911,969,0.97 [0.76-1.24],0.807563785667421
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22579,637,1.06 [0.78-1.43],0.730198402567837
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21530,41,1.52 [0.46-5.06],0.4934528998410025
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24273,144,0.89 [0.47-1.70],0.7287109204968742
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21630,141,0.84 [0.44-1.61],0.597579089842601
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21543,54,0.95 [0.33-2.70],0.922976495269188
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18840,34,2.39 [0.62-9.24],0.2055991492898928
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24182,763,1.56 [1.18-2.07],0.00181100806807
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9994,65,1.05 [0.40-2.79],0.918920168245929
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13308,72,0.76 [0.30-1.91],0.5634916914957925
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24383,279,0.88 [0.55-1.40],0.5762503845646807
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,24160,56,1.23 [0.43-3.54],0.6972282328999055
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23991,572,3.69 [2.67-5.09],2.454447149540692e-15
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24487,20,14.23 [2.71-74.75],0.0017067596002122
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24494,167,1.37 [0.75-2.50],0.302038304334883
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Cystitis,22643,141,0.54 [0.28-1.03],0.0626725128223722
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Dialysis,23463,44,2.01 [1.27-3.18],0.0029489519401455
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10661,1016,1.07 [0.83-1.38],0.5945119793021387
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13414,178,0.79 [0.44-1.42],0.4293460089642152
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Endometriosis,10046,117,1.20 [0.58-2.48],0.6242925249224739
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10270,341,0.79 [0.51-1.21],0.2764145468346919
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10314,385,0.56 [0.38-0.83],0.0042473762914112
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20776,3802,0.91 [0.81-1.04],0.1718918025039042
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24526,59,5.63 [2.09-15.15],0.0006226563229957
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Hydrocele,9717,72,0.88 [0.34-2.26],0.7921157466096812
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,23340,200,1.67 [0.96-2.92],0.0710587458555501
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10326,681,1.08 [0.79-1.46],0.6427013667446847
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13293,210,0.62 [0.37-1.07],0.0845599863431317
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9737,92,1.54 [0.67-3.56],0.3108084238219444
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Irregular menses,13301,109,0.55 [0.26-1.18],0.1236707822206969
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10195,266,0.80 [0.49-1.30],0.3720227919201775
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22561,59,1.24 [0.45-3.42],0.6728524627605863
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11190,1261,0.70 [0.56-0.87],0.0012421086106405
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9692,47,0.72 [0.23-2.28],0.5805950715389094
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10017,88,0.43 [0.19-0.98],0.0447400115978249
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24640,37,1.02 [0.29-3.61],0.9810498255210232
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24645,43,0.80 [0.44-1.44],0.4537149986519695
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23871,1369,0.99 [0.80-1.22],0.9022229561466332
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22936,434,0.81 [0.56-1.18],0.2725561491186175
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13292,56,0.87 [0.31-2.48],0.8001764920892298
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24603,276,1.77 [1.11-2.83],0.0162206765533078
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9785,140,1.33 [0.67-2.64],0.4091511263076383
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9752,107,1.09 [0.50-2.36],0.8260903876062777
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9712,67,0.92 [0.35-2.43],0.8667027497680512
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24617,50,1.09 [0.36-3.27],0.8752239314405956
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,23506,1004,1.08 [0.84-1.37],0.5506165165341528
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13190,107,0.85 [0.40-1.79],0.6637842995692087
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,10002,73,0.38 [0.15-0.95],0.0376643922063547
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10139,210,0.77 [0.45-1.31],0.3331287371930955
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9983,54,1.06 [0.36-3.06],0.9206900509882068
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,10025,96,0.64 [0.29-1.42],0.2755001320018576
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23372,232,1.60 [0.95-2.68],0.0768196456074295
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,24422,95,2.08 [0.93-4.62],0.0737273953534693
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10088,159,0.69 [0.37-1.29],0.2479020923588734
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,10000,71,0.52 [0.20-1.32],0.1664039672861266
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10308,379,0.65 [0.44-0.97],0.0357503896664807
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9988,59,1.03 [0.37-2.83],0.9577154677881076
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10266,337,0.60 [0.39-0.91],0.0161887763182591
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24509,42,1.90 [0.58-6.30],0.2912251854979
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9745,100,1.30 [0.58-2.89],0.5240985397894697
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24485,1345,1.82 [1.47-2.25],2.8114418540108084e-08
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23266,126,2.19 [1.10-4.38],0.0264176674145845
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23478,59,2.62 [0.94-7.25],0.0647031255389748
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,24166,62,0.37 [0.14-0.98],0.0458944824890436
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22656,154,1.08 [0.57-2.02],0.819970283272837
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24441,337,0.83 [0.55-1.28],0.4043969794422197
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Uterine polyps,10018,89,0.38 [0.17-0.87],0.0217901281183279
